van Bodegraven, A A
Editorial: nocebo effect and switching to biosimilars. [electronic resource]
- Alimentary pharmacology & therapeutics 03 2018
- 850-851 p. digital
Publication Type: Editorial; Comment
1365-2036
10.1111/apt.14509 doi
Biosimilar Pharmaceuticals
Humans
Inflammatory Bowel Diseases
Infliximab
Nocebo Effect
Prospective Studies